|
시장보고서
상품코드
2075233
올리고뉴클레오티드 합성 시장 : 장비 및 서비스별, 기술별, 핵산별, 용도별, 최종사용자별, 지역별Oligonucleotide Synthesis Market,By Equipment and Services, By Technology, By Nucleic Acid, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
올리고뉴클레오티드 합성 시장 규모는 2026년에 52억 1,000만 달러로 추계되고 있으며, 2033년까지 108억 9,000만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 11.1%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 52억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 11.10% | 2033년 시장 규모 예측 : | 108억 9,000만 달러 |
올리고뉴클레오티드는 중합효소 연쇄 반응(PCR), PCR 분석법 및 생물학적 관련 유전자 패널에서 프라이머로 일반적으로 사용됩니다. 안티센스 올리고뉴클레오티드는 mRNA의 처리나 번역을 억제함으로써 단백질 합성 수준을 낮추기 위해 사용됩니다. 올리고뉴클레오티드의 그 밖의 용도로는 DNA 염기서열 분석, DNA 마이크로어레이, 형광 in situ 하이브리드화(FISH), 그리고 핵산 랩타머 등이 있습니다. 또한 많은 제약 기업이 핵산 기반 치료제 개발에 주력하고 있으므로 올리고뉴클레오티드의 수요가 증가하고 있습니다. 따라서 시장에 진출한 각 기업은 생산 시설 확충에 주력하고 있으며, 이는 예측 기간 중 시장 성장을 지원할 것으로 전망됩니다. 예를 들어 2020년 8월, 애지런트 테크놀러지스는 콜로라도주 프레더릭에 위치한 최첨단 생산 시설의 확장을 발표했습니다. 이 시설에서는 COVID-19, 심혈관 질환, 암, 희귀 질환, 감염증 및 기타 질환의 치료제로 활용될 가능성이 있는 올리고뉴클레오티드의 개발 및 제조를 진행하고 있습니다.
시장 역학 :
주요 기업은 제휴, 파트너십, 계약 등 다양한 비유기적 성장 전략에 주력하고 있으며, 이는 예측 기간 중 전 세계 올리고뉴클레오티드 합성 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2020년 8월 5일, 신약 개발 기업인 에보텍 SE(Evotec SE)는 신약 개발 기업인 세카르나 파마슈티컬스 GmbH & Co. KG와 안티센스 올리고뉴클레오티드 치료법 개발을 위한 전략적 제휴를 체결했습니다.
또한 2019년 11월에는 펩티드 및 장비 제조 기업인 CSBio가 이온교환수지 및 흡착·분리 수지 공급업체인 Sunresin과, 상업 규모의 올리고뉴클레오티드 합성에 최적화된 폴리스티렌 수지 개발을 목적으로 하는 공동 연구 계약을 체결했습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 다음의 매개변수를 바탕으로 전 세계 올리고뉴클레오티드 합성 시장의 주요 기업 개요을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 시장내 입지, 유통 전략, 주요 발전 사항, 전략 및 향후 계획입니다.
- 이 보고서에서 얻을 수 있는 인사이트는 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내리는 데 도움이 됩니다.
- 이 보고서는 세계의 올리고뉴클레오티드 합성 시장을 다루며, 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 올리고뉴클레오티드 합성 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 올리고뉴클레오티드 합성 시장 : 장비·서비스별, 2021-2033년
제5장 세계의 올리고뉴클레오티드 합성 시장 : 기술별, 2021-2033년
제6장 세계의 올리고뉴클레오티드 합성 시장 : 핵산별, 2021-2033년
제7장 세계의 올리고뉴클레오티드 합성 시장 : 용도별, 2021-2033년
제8장 세계의 올리고뉴클레오티드 합성 시장 : 최종사용자별, 2021-2033년
제9장 세계의 올리고뉴클레오티드 합성 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSA 26.07.08Oligonucleotide Synthesis Market is estimated to be valued at USD 5.21 Bn in 2026 and is expected to reach USD 10.89 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.21 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.10% | 2033 Value Projection: | USD 10.89 Bn |
Oligonucleotides are commonly used as primers for polymerase chain reaction (PCR), PCR assays, and panels for biologically related genes. Antisense oligonucleotides are used to reduce levels of protein synthesis by inhibiting mRNA processing or translation. Other uses of oligonucleotides include DNA sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), and nucleic acid aptamers. Moreover, many pharmaceutical companies are focusing on developing nucleic acid-based therapeutics due to which the demand of oligonucleotide is increasing. Hence, market players are focusing on expanding their manufacturing facilities, which is expected to boost the market growth over the forecast period. For instance, in August 2020, Agilent Technologies Inc., announced the expansion of its state-of-the-art production facility in Frederick, Colorado, which develops manufactures oligos that hold potential to be used as treatments for diseases such as COVID-19, cardiovascular disease, cancer, rare and infectious diseases, and other conditions.
Market Dynamics:
Key players are focusing on various inorganic growth strategies such as collaborations, partnerships and agreements, which is expected to propel the growth of the global oligonucleotide synthesis market during the forecast period. For instance, on August 05, 2020, Evotec SE, a drug discovery and development company entered into a strategic partnership with Secarna Pharmaceuticals GmbH & Co. KG, a drug discovery company, for the development of antisense oligonucleotide therapies.
Moreover, in November 2019, CSBio, a peptide and instrumentation manufacturing company entered into a collaboration with Sunresin, a supplier of ion exchange resin and absorption & separation resin for the development of an optimized polystyrene resin for commercial scale oligonucleotide synthesis.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global oligonucleotide synthesis market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
- Key companies covered as a part of this study include Thermo Fisher Scientific, Sigma-Aldrich Corporation, GE Healthcare, Integrated DNA Technologies, Inc., TriLink BioTechnologies, Inc, BioAutomation Corporation, Twist Bioscience, Shanghai SynTheAll Pharmaceutical Co., CUSABIO Technology LLC, Synbio Technologies, GENEWIZ, Eurofins Scientific, Agilent Technologies, Kaneka Eurogentec S.A., and LGC, Biosearch Technologies
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, market expansion, and marketing tactics
- The global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market.
Detailed Segmentation:
- Global Oligonucleotide Synthesis Market, By Equipment & Services (Revenue, USD Bn, 2021 - 2033)
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- Global Oligonucleotide Synthesis Market, By Technology (Revenue, USD Bn, 2021 - 2033)
- Column-based
- Microarray-based
- Global Oligonucleotide Synthesis Market, By Nucleic Acid Type (Revenue, USD Bn, 2021 - 2033)
- DNA
- RNA
- Global Oligonucleotide Synthesis Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Drug Discovery
- Therapeutics
- Global Oligonucleotide Synthesis Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- Global Oligonucleotide Synthesis Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- DNA
- RNA
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- U.S.
- Canada
- By Equipment & Services
- Latin America
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- DNA
- RNA
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Equipment & Services
- Europe
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- DNA
- RNA
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Equipment & Services
- Asia Pacific
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- DNA
- RNA
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Equipment & Services
- Middle East
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- DNA
- RNA
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Equipment & Services
- Africa
- By Equipment & Services
- Equipment/Synthesizer
- Reagents
- Services
- Oligo Synthesis
- Modification
- Purification
- By Technology
- Column-based
- Microarray-based
- By Nucleic Acid Type
- DNA
- RNA
- By Application
- Drug Discovery
- Therapeutics
- By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-Biotechnology Companies
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- By Equipment & Services
- Company Profiles
- Thermo Fisher Scientific
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sigma-Aldrich Corporation
- GE Healthcare
- Integrated DNA Technologies, Inc.
- TriLink BioTechnologies, Inc
- BioAutomation Corporation
- Twist Bioscience
- Shanghai SynTheAll Pharmaceutical Co.
- CUSABIO Technology LLC
- Synbio Technologies
- GENEWIZ
- Eurofins Scientific
- Agilent Technologies
- Kaneka Eurogentec S.A.
- LGC, Biosearch Technologies
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Equipment and Services
- Market Snippet, By Technology
- Market Snippet, By Nucleic Acid
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Oligonucleotide Synthesis Market, By Equipment and Services, 2021- 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Equipment and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Nucleic Acid Synthesizer
- Peptide Synthesizer
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Oligo Synthesis
- Modification
- Purification
5. Global Oligonucleotide Synthesis Market, By Technology, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- ColuBn-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Microarray-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
6. Global Oligonucleotide Synthesis Market, By Nucleic Acid, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- RNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
7. Global Oligonucleotide Synthesis Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
8. Global Oligonucleotide Synthesis Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
- Pharmaceutical-biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
9. Global Oligonucleotide Synthesis Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Equipment and Services, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Nucleic Acid, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 -2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific Inc.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Merck KGaA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Twist Bioscience
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- STA Pharmaceutical Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- KINOVATE LIFE SCIENCES
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CUSABIO TECHNOLOGY LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Synbio Technologies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- GENEWIZ
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Maravai LifeSciences Holdings, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Biogen
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Eurofins Scientific
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sarepta Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- LGC Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Kaneka Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Biotage
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Nitto Denko Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Thermo Fisher Scientific Inc.*
11. Section
- References
- Research Methodology
- About us and Sales Contact
